Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04781686
What this trial is testing

Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Zhou Fuxiang 35
Testing effectiveness (Phase 2)Looking for participantsNCT06339619
What this trial is testing

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32
Not applicableUnknownNCT04782622
What this trial is testing

The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy

Who this might be right for
Lung Cancer
The Affiliated Hospital of Qingdao University 60
Testing effectiveness (Phase 2)Study completedNCT04195828
What this trial is testing

Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Fujian Medical University 106
Testing effectiveness (Phase 2)UnknownNCT04934618
What this trial is testing

A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Nanfang Hospital, Southern Medical University 85
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT04035876
What this trial is testing

Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplant
Zhejiang University 120
Testing effectiveness (Phase 2)Looking for participantsNCT07289997
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

Who this might be right for
AFP Gastric or Gastroesophageal Junction AdenocarcinomaPD-1/CTLA-4AFPGC+1 more
Hebei Medical University Fourth Hospital 39
Testing effectiveness (Phase 2)UnknownNCT03793725
What this trial is testing

A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Yanqiao Zhang 30
Testing effectiveness (Phase 2)Looking for participantsNCT07334483
What this trial is testing

Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC

Who this might be right for
HCC
GrandPharma (China) Co., Ltd. 120
Testing effectiveness (Phase 2)UnknownNCT03412994
What this trial is testing

Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Liqiang Zhong 60
Testing effectiveness (Phase 2)UnknownNCT05932264
What this trial is testing

Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLCNon-small Cell Lung Cancer
Sun Yat-sen University 60
Testing effectiveness (Phase 2)UnknownNCT03192735
What this trial is testing

Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Who this might be right for
Apatinib CombinedSOXNeoadjuvant Therapy+1 more
Chang-Ming Huang, Prof. 50
Testing effectiveness (Phase 2)UnknownNCT04453930
What this trial is testing

Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC）

Who this might be right for
Small Cell Lung Carcinoma
Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)UnknownNCT06140732
What this trial is testing

Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma

Who this might be right for
ChordomaChemotherapy Effect
Xuanwu Hospital, Beijing 30
Testing effectiveness (Phase 2)UnknownNCT05839197
What this trial is testing

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

Who this might be right for
Macrotrabecular Massive Hepatocellular Carcinoma
Wan-Guang Zhang 38
Not applicableUnknownNCT03398122
What this trial is testing

Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 248
Large-scale testing (Phase 3)Not Yet RecruitingNCT06539091
What this trial is testing

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerEfficacySafety+2 more
Anhui Provincial Hospital 51
Testing effectiveness (Phase 2)UnknownNCT04201990
What this trial is testing

Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer

Who this might be right for
Lung Cancer
ShiYue Li 20
Testing effectiveness (Phase 2)Study completedNCT03652857
What this trial is testing

Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung Cancer
Yongchang Zhang 30
Next Page